Politico's Pulse Check

After years of anticipation, California Gov. Gavin Newsom said the state would contract with Civica, a Utah-based generic pharmaceutical company, to start producing California-branded insulin, available for $30 for a 10 mL vial. Once the Food and Drug Administration approves the new insulin, Civica can begin manufacturing. Reporter Rachel Bluth talks with host Ben Leonard about about the deal.